FCGR2A and acute myeloid leukemia: In the study by Saito et al., CD32A was also exclusively expressed in CD34+CD38− LSCs (34% of the AML samples analyzed) but not in healthy HSCs, and CD32A depletion did not affect healthy HSC engraftment (34).